Growth Capital For Life Sciences & Healthcare
Telegraph Hill Partners is a venture capital firm dedicated to helping life science, medical device and healthcare companies achieve their growth objectives. When you work with us, you get an experienced team that knows how to drive growth and profitability while maintaining the vision and integrity of the organization.
We seek to partner with innovative companies by providing capital and strategic guidance to help them grow.
Latest News & Announcements
LakePharma Expands Service Capability with Purchase of Carterra™ High Throughput Antibody Characterization LSA™ Instrumentation
First Contract Development & Manufacturing Organization to Install Carterra’s Next Generation Label-Free Biosensor to Support Antibody Discovery Services Business Salt Lake City, UT, USA and South San Francisco, CA, USA, April 26th 2018. Carterra™ Inc., a provider of innovative drug discovery [...]
RareCyte introduces the CyteFinder® HT instrument at AACR for high throughput slide-based imaging optimized for single cell Liquid Biopsy
Seattle, WA, April 16, 2018 – RareCyte, Inc., a global rare cell detection and liquid biopsy company announces its newest product, CyteFinder HT in conjunction with the American Association for Cancer Research (AACR) Annual Meeting in Chicago April 15 through 18. CyteFinder HT, RareCyte’s newest mem [...]
AGENA AND SIMCEREDX ANNOUNCE STRATEGIC PARTNERSHIP TO DEVELOP AND COMMERCIALIZE COMPANION DIAGNOSTICS IN CHINA
SAN DIEGO, Calif., and NANJING, JiangSu, March 26, 2018 – Agena Bioscience (Agena) and Simcere Diagnostics (Simceredx), the subsidiary of SIMCERE Pharmaceutical Group, announced today the signing of a strategic partnership agreement focusing on expanding the use of Agena’s MassARRAY® System for comp [...]